- Home
- QCLS vs OSRH Comparison
QCLS vs OSRH Comparison
Compare QCLS & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCLS
- OSRH
- Stock Information
- Founded
- QCLS 2014
- OSRH N/A
- Country
- QCLS United States
- OSRH United States
- Employees
- QCLS N/A
- OSRH N/A
- Industry
- QCLS Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OSRH
- Sector
- QCLS Health Care
- OSRH
- Exchange
- QCLS Nasdaq
- OSRH Nasdaq
- Market Cap
- QCLS 12.5M
- OSRH 13.2M
- IPO Year
- QCLS N/A
- OSRH N/A
- Fundamental
- Price
- QCLS $3.80
- OSRH $0.71
- Analyst Decision
- QCLS
- OSRH
- Analyst Count
- QCLS 0
- OSRH 0
- Target Price
- QCLS N/A
- OSRH N/A
- AVG Volume (30 Days)
- QCLS 1.3M
- OSRH 2.0M
- Earning Date
- QCLS 11-13-2025
- OSRH 11-24-2025
- Dividend Yield
- QCLS N/A
- OSRH N/A
- EPS Growth
- QCLS N/A
- OSRH N/A
- EPS
- QCLS N/A
- OSRH N/A
- Revenue
- QCLS N/A
- OSRH $104,735.00
- Revenue This Year
- QCLS N/A
- OSRH N/A
- Revenue Next Year
- QCLS N/A
- OSRH N/A
- P/E Ratio
- QCLS N/A
- OSRH N/A
- Revenue Growth
- QCLS N/A
- OSRH N/A
- 52 Week Low
- QCLS $3.24
- OSRH $0.45
- 52 Week High
- QCLS $174.27
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- QCLS N/A
- OSRH 55.35
- Support Level
- QCLS N/A
- OSRH $0.59
- Resistance Level
- QCLS N/A
- OSRH $0.82
- Average True Range (ATR)
- QCLS 0.00
- OSRH 0.11
- MACD
- QCLS 0.00
- OSRH 0.02
- Stochastic Oscillator
- QCLS 0.00
- OSRH 49.99
About QCLS Q/C Technologies Inc. Common Stock
Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.